Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
20.8%
% of CNCR's 72 holdings also in IDNA
32.6%
% of IDNA's 51 holdings also in CNCR
Overlap by Weight
Sector Drift (CNCR minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CNCR |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
SPRINGWORKS THERAPEUTICS, INC. | 2.7% | 5.1% | 2.7% |
|
EXELIXIS INC | 2.5% | 4.7% | 2.5% |
|
ARCELLX, INC. | 1.7% | 3.9% | 1.7% |
|
REVOLUTION MEDICINES, INC. | 1.6% | 3.7% | 1.6% |
 |
BIONTECH SE SPONSORED ADR | 1.5% | 3.7% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
CNCR Overweight Relative to IDNA
|
RECURSION PHARMACEUTICALS, INC CLASS | 3.6% |
|
INTREXON CORP | 3.4% |
|
COMPASS THERAPEUTICS, INC. | 2.7% |
|
GENELUX CORP. | 2.5% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% |
|
SCHRODINGER, INC. | 2.2% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | 2.1% |
|
MONTE ROSA THERAPEUTICS, INC. | 2.1% |
|
REPLIMUNE GROUP, INC. | 2.1% |
|
BLUEPRINT MEDICINES CORP. | 2.0% |
CNCR Underweight Relative to IDNA
 |
BEIGENE, LTD. | -5.6% |
 |
SANOFI-AVENTIS | -5.4% |
 |
ROCHE HOLDING LTD | -5.4% |
 |
ASTRAZENECA PLC | -5.2% |
|
GSK PLC | -5.2% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.7% |
 |
GENMAB A/S | -4.3% |
|
INCYTE CORP | -4.1% |
|
MODERNA, INC. | -3.6% |
|
TWIST BIOSCIENCE CORP. | -3.4% |